MUFG Securities EMEA’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
5,747
-270
-4% -$51.6K 0.01% 379
2026
Q1
$1.1M Hold
6,017
0.02% 379
2025
Q4
$1.06M Buy
6,017
+3,211
+114% +$525K 0.01% 400
2025
Q3
$393K Buy
2,806
+2,375
+551% +$321K 0.01% 413
2025
Q2
$54.1K Buy
+431
New +$53.7K ﹤0.01% 431
2022
Q2
Sell
-745
Closed -$157K 133
2022
Q1
$157K Sell
745
-11,980
-94% -$2.61M ﹤0.01% 120
2021
Q4
$3.05M Buy
+12,725
New +$3.27M 0.05% 96
2021
Q2
Sell
-6,395
Closed -$1.79M 309
2021
Q1
$1.79M Sell
6,395
-650
-9% -$175K 0.01% 276
2020
Q4
$1.73M Sell
7,045
-68,984
-91% -$17.8M 0.01% 296
2020
Q3
$21.6M Buy
76,029
+1,095
+1% +$305K 0.2% 79
2020
Q2
$20M Sell
74,934
-100,066
-57% -$30.1M 0.17% 106
2020
Q1
$55.4M Buy
175,000
+60,000
+52% +$18.2M 0.56% 33
2019
Q4
$34.1M Buy
115,000
+36,300
+46% +$10.1M 0.27% 83
2019
Q3
$18.3M Buy
78,700
+3,700
+5% +$862K 0.22% 80
2019
Q2
$17.5M Sell
75,000
-115,600
-61% -$26.7M 0.19% 93
2019
Q1
$45.1M Buy
190,600
+100
+0.1% +$31.5K 0.52% 36
2018
Q4
$57.3M Buy
190,500
+91,039
+92% +$29.1M 0.58% 25
2018
Q3
$35.1M Buy
99,461
+99,225
+42,044% +$34.2M 0.5% 42
2018
Q2
$68K Sell
236
-19,764
-99% -$5.56M ﹤0.01% 276
2018
Q1
$5.48M Hold
20,000
0.12% 125
2017
Q4
$6.37M Buy
+20,000
New +$6.42M 0.15% 94

Other funds holding BIIB

MUFG Securities EMEA's BIIB Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Biogen (BIIB) stake by 4.5% in Q2 2026, selling an estimated $51.6K and leaving 5,747 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #379.

MUFG Securities EMEA first reported a position in BIIB in Q4 2017 and has held it in 21 quarters since. The position peaked at $57.3M in Q4 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • MUFG Securities EMEA held 5,747 shares of Biogen worth $1.24M as of Q2 2026.
  • MUFG Securities EMEA sold 270 Biogen shares in Q2 2026, an estimated $51.6K.
  • Biogen made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #379 holding.
  • MUFG Securities EMEA first reported a position in Biogen in Q4 2017 and has held it in 21 quarters since.
  • MUFG Securities EMEA's Biogen position peaked at $57.3M in Q4 2018.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.